Target intelligence / Profile preview

Nasal mucosa and nasal mucus

Molecular classification
Tissue, Biological secretion, Physical barrier
01

Overview

The nasal mucosa is the specialized mucous membrane lining the nasal cavity, composed of a ciliated pseudostratified columnar epithelium, goblet cells, and a highly vascularized lamina propria (StatPearls: Anatomy, Head and Neck, Nasal Cavity, 2023). It serves as the primary physiological barrier and interface between the respiratory system and the external environment, facilitating air humidification, temperature regulation, and the filtration of inhaled particles. Nasal mucus, a complex secretion containing water, electrolytes, and mucin glycoproteins like MUC5AC and MUC5B, acts as a trap for pathogens and allergens, which are subsequently cleared via mucociliary transport (PubMed: Nasal mucus: a physical and chemical barrier, 2011). In pathological conditions such as allergic rhinitis or chronic sinusitis, the mucosa undergoes inflammatory changes and mucus production increases in volume or viscosity, leading to nasal obstruction and impaired clearance. While not a single molecular target, this tissue-secretion complex is the site of action for various pharmacological agents, including topical corticosteroids that suppress mucosal inflammation and decongestants that target adrenergic receptors to reduce vascular engorgement (Journal of Controlled Release: Nasal drug delivery, 2014). Chronic use of certain topical agents can lead to safety issues such as rhinitis medicamentosa, characterized by rebound mucosal swelling (StatPearls: Rhinitis Medicamentosa, 2023).

Other names
Schneiderian membraneNasal liningNasal secretionRespiratory mucosaNasal airway surface liquid
02

Mechanism of action

Drugs acting on this site typically function by inducing vasoconstriction of mucosal blood vessels (alpha-adrenergic agonists), reducing inflammatory cytokine production in mucosal cells (corticosteroids), or chemically disrupting disulfide bonds in mucin glycoproteins to reduce mucus viscosity (mucolytics).

03

Biological functions

Physical barrierMucociliary clearanceHumidificationImmune defenseOlfaction supportThermoregulation
04

Disease associations

Allergic rhinitisChronic rhinosinusitisInfectionCystic fibrosisCommon coldRhinitis medicamentosa
05

Safety considerations

Rhinitis medicamentosa (rebound congestion)Mucosal atrophyEpistaxis (nosebleeds)Ciliary toxicitySeptal perforation
06

Interacting drugs

Oxymetazoline

6 more in the full profile.

07

Biomarkers

Mucociliary clearance time (Saccharin test)Nasal peak inspiratory flow (NPIF)Eosinophil count in nasal smearMUC5AC expression levelsNasal airway resistance

Beyond the preview

Go deeper on Nasal mucosa and nasal mucus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nasal mucosa and nasal mucus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call